Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Mitral Valve Disease Market From 2025 To 2029?
The market scale for mitral valve disease has seen robust growth in the past. Expectations are for it to rise from $3 billion in 2024 to reach $3.28 billion by 2025, with the compound annual growth rate (CAGR) touching 9.1%. Factors contributing to growth in the historical period include initiatives for patient education, satisfactory reimbursement policies and insurance coverage, increases in healthcare spending, heightened awareness and screening efforts, and a broader market reach.
The market size for mitral valve disease is anticipated to experience robust growth in the coming years, expanding to$4.65 billion by 2029 with a compound annual growth rate (CAGR) of 9.2%. The anticipated growth in the forecast period is associated with the rising occurrence of mitral valve disease, greater acceptance of minimally invasive procedures, skyrocketing innovations in cardiac valve surgeries, increased venture capital investments, and a growing interest among manufacturers. Prominent trends during the forecast period encompass technological upgrades, developments in transcatheter technologies, and continued technological progression in surgical procedures.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp
What Are the Core Market Drivers Propelling Growth in the Mitral Valve Disease Industry?
The growth of the mitral valve disease market is anticipated to be fueled by the escalating incidence of vascular heart diseases. These diseases involve a collection of conditions that affect the blood vessels that supply the heart or are located in the heart itself. Factors such as lifestyle choices, demographic shifts, medical conditions, environmental influences, and genetic factors contribute to the rising occurrence of vascular heart diseases. Illnesses like ischemic heart disease and hypertension which are vascular heart diseases can indirectly lead to mitral valve disease by disrupting the heart’s structure and function creating conditions that impact the mitral valve. In the context of Australia, for example, in 2024, data from the Australian Bureau of Statistics 2020-21 showcased that the National Health Survey led by the Australian Institute of Health and Welfare, revealed an increase in the death rate from cardiovascular disease per 100,000 population from 143.7 in 2021 to 148.2 in 2022 for males. Therefore, the escalating incidence of vascular heart diseases is fueling the growth of the mitral valve disease market.
How Is the Mitral Valve Disease Market Segmented?
The mitral valve diseasemarket covered in this report is segmented –
1) By Treatment Type: Mitral Valve Repair; Mitral Valve Replacement; Cardiac Resynchronization Therapy; Mitral Valve Therapeutics
2) By Indication: Mitral Valve Stenosis; Mitral Valve Prolapse; Mitral Valve Regurgitation
3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Mitral Valve Repair: Surgical Repair; Minimally Invasive Repair; Percutaneous Mitral Valve Repair
2) By Mitral Valve Replacement: Mechanical Valve Replacement; Biological Valve Replacement; Transcatheter Mitral Valve Replacement (TMVR)
3) By Cardiac Resynchronization Therapy: Pacemaker Therapy; Implantable Cardioverter-Defibrillators (ICD); Biventricular Pacing
4) By Mitral Valve Therapeutics: Pharmacological Treatments; Anticoagulation Therapy; Mitral Valve Repair Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=16480&type=smp
Which Regions Are Driving the Next Phase of the Mitral Valve Disease Market Growth?
Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Mitral Valve Disease Industry?
Major firms in the mitral valve disease market are innovating stented tissue valves to meet the increasing need for less intrusive treatment alternatives. These stented tissue valves are engineered to provide a durable and dependable solution, presenting patients with choices other than traditional surgical procedures. For example, in April 2024, healthcare firm Medtronic, based out of Ireland, introduced the Avalus Ultra valve. It is a superior surgical aortic tissue valve with an improved design, intended to ease its use in implantation and the long-term care of patients. With a decade worth of clinical experience with the original Avalus valve, the latest Avalus Ultra version provides a lower valve profile for easier installation, a PEEK base frame ensuring consistent circularity, and a top-tier Effective Orifice Area (EOA) which can potentially facilitate improved blood circulation. Also, it features a radiopaque coil for easy detection in future valve-in-valve operations.
View the full report here:
https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report
How Is the Mitral Valve Disease Market Defined and What Are Its Core Parameters?
Mitral valve disease is a disorder impacting the mitral valve, which controls blood movement between the heart’s left atrium and left ventricle. It can result in the valve becoming narrowed or leaky, disrupting normal blood flow and causing issues like breathlessness, tiredness, and abnormal heart rhythms. The primary aim of managing mitral valve disease is to ensure proper blood flow through the heart and to prevent complications.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16480
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model